Press Releases :: Ligand Pharmaceuticals, Inc. (LGND)

Press Releases

Ligand to Report Second Quarter 2018 Results on August 6th

July 9, 2018

Ligand Receives $47 Million from WuXi Biologics for Expansion of Worldwide OmniAb® Platform License Agreement

June 27, 2018

Ligand Prices Offering of $650 Million of Convertible Senior Notes

May 18, 2018

Ligand Announces Proposed Offering of $650 Million of Convertible Senior Notes

May 16, 2018

Ligand to Participate in Upcoming Investor Conferences

May 11, 2018

Ligand Reports First Quarter 2018 Financial Results

May 8, 2018

Ligand to Report First Quarter 2018 Results on May 8th

April 24, 2018

Ligand Enters into Agreement with venBio to Make Worldwide OmniAb® Platform License Accessible to Portfolio Companies

March 30, 2018

Ligand Licenses Glucagon Receptor Antagonist Program to Roivant Sciences

March 6, 2018

Ligand to Participate in Two Upcoming Investor Conferences

March 5, 2018

1
2
3
4
5
6
7
8
9
10
...36
Next »